This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. (INO) rose 5.23% to $1.61 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.11% to 49,071.56 and the NASDAQ Composite Index  falling 0.72% to 23,685.12.
Inovio Pharmaceuticals Inc. closed 45.95% short of its 52-week high of $2.98, which the company achieved on September 9th.
The stock outperformed some of its competitors Thursday, as Johnson &amp; Johnson (JNJ) fell 0.19% to $227.29, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. (PFE) rose 0.93% to $26.10.
Trading volume (1.9 M) eclipsed its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 29, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-29-26 1726ET

SRPT

IBBQ

<p>Inovio Pharmaceuticals Inc. (INO) shares rose 5.23% to $1.61 on a mixed trading day, outperforming competitors like Johnson & Johnson and Statera Biopharma. The Dow Jones increased by 0.11%, while NASDAQ fell by 0.72%. Inovio's stock remains 45.95% below its 52-week high of $2.98, reached on September 9th. Trading volume was 1.9 million, surpassing the 50-day average of 1.5 million.</p>

Dow Jones

First Trust NYSE Arca Biotech Index Fd

Sarepta Therap

VG Health

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

Invesco Nasdaq Biotechnology ETF

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day